Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study

被引：0
|
作者：
Hubert G Nüßlein
Rieke Alten
Mauro Galeazzi
Hanns-Martin Lorenz
Dimitrios Boumpas
Michael T Nurmohamed
William G Bensen
Gerd R Burmester
Hans-Hartmut Peter
Franz Rainer
Karel Pavelka
Melanie Chartier
Coralie Poncet
Christiane Rauch
Manuela Le Bars
机构：
[1] University of Erlangen-Nuremberg,Schlosspark
[2] University Medicine,Klinik
[3] University of Siena,Institute of Rheumatology and Clinic of Rheumatology
[4] University Hospital Heidelberg,undefined
[5] University of Crete,undefined
[6] VU University Medical Center/Jan van Breemen Research Institute,undefined
[7] St. Joseph’s Hospital/McMaster University,undefined
[8] Charité-Universitätsmedizin Berlin,undefined
[9] University Medical Center Freiburg,undefined
[10] Hospital Barmherzige Brueder,undefined
[11] Charles University,undefined
[12] Chiltern International,undefined
[13] Docs International,undefined
[14] Bristol-Myers Squibb,undefined
[15] Bristol-Myers Squibb,undefined
来源：
BMC Musculoskeletal Disorders | / 15卷
关键词：
Rheumatoid arthritis; Biological agents; Abatacept; Effectiveness; Safety; Registries;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Alten, Rieke
    Mariette, Xavier
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Galeazzi, Mauro
    Navarro, Federico
    Chartier, Melanie
    Heitzmann, Julia
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (05) : 1413 - 1424
  • [32] Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study
    Rieke Alten
    Xavier Mariette
    Hanns-Martin Lorenz
    Hubert Nüßlein
    Mauro Galeazzi
    Federico Navarro
    Melanie Chartier
    Julia Heitzmann
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    [J]. Clinical Rheumatology, 2019, 38 : 1413 - 1424
  • [33] Safety and Effectiveness of Ruxolitinib in Real-World Patients with Myelofibrosis: A 2-Year Observational Study from Taiwan
    Kuo, Ming-Chung
    Lin, Chien-Chin
    Lin, Hsuan-Yu
    Gau, Jyh-Pyng
    Wang, Ming-Chung
    Chang, Ming-Chih
    Chen, Tsung-Chih
    Yeh, Shih-Peng
    Chen, Yeu-Chin
    Huang, Cih-En
    Chiang, I-Ju
    Chung, Chu-Han
    Lee, Yee-Ming
    Ku, Fan-Chen
    Chang, Cheng-Shyong
    [J]. BLOOD, 2022, 140 : 9709 - 9710
  • [34] US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry
    Strober, Bruce E.
    Germino, Rebecca
    Guana, Adriana
    Greenberg, Jeffrey D.
    Litman, Heather J.
    Guo, Ning
    Lebwohl, Mark
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (04) : 333 - 341
  • [35] Effectiveness of Upadacitinib in the Treatment of Rheumatoid Arthritis: Analysis of 6-Month Real-World Data from the United Rheumatology Normalized Integrated Community Evidence (UR-NICE™) Database
    Gibofsky, Allan
    Pearson, Mark
    Concoff, Andrew
    Shmagel, Anna K.
    Zueger, Patrick
    Song, Yanna
    Smith, Lauren
    Wright, Grace
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 590 - 592
  • [36] EFFECTIVENESS OF UPADACITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: ANALYSIS OF 6-MONTH REAL-WORLD DATA FROM THE UNITED RHEUMATOLOGY NORMALIZED INTEGRATED COMMUNITY EVIDENCE (UR-NICETM) DATABASE
    Gibofsky, A.
    Pearson, M. E.
    Concoff, A.
    Shmagel, A.
    Zueger, P.
    Song, Y.
    Smith, L.
    Wright, G. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 621 - 622
  • [37] CHARACTERISTICS AND 6-MONTH OUTCOMES AMONG REAL-WORLD PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING UPADACITINIB: ANALYSIS FROM THE CORRONA REGISTRY
    Kremer, J. M.
    Tundia, N.
    McLean, R.
    Blachley, T.
    Maniccia, A.
    Pappas, D. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 446 - 446
  • [38] A real-world 2-year prospective study of medication tapering in patients with well-controlled rheumatoid arthritis within the rheumatoid arthritis medication tapering (RHEUMTAP) cohort
    Tageldin, Mohamed
    Wilson, Nicole
    Yin, Yue
    Sharma, Tarun S.
    [J]. RHEUMATOLOGY, 2023, 62 : IV8 - IV13
  • [39] Effectiveness of Upadacitinib in Patients with Rheumatoid Arthritis in German Real-World Practice: Interim Results from a Post-Marketing Observational Study
    Witte, Torsten
    Kiltz, Uta
    Haas, Florian
    Riechers, Elke
    Prothmann, Ulrich
    Adolf, Daniela
    Holland, Carsten
    Hecht, Rouven
    Roessler, Alexander
    Famulla, Kirsten
    Goetz, Konrad
    Krueger, Klaus
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1720 - 1723
  • [40] Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study
    Mu, Rong
    Li, Chun
    Li, Xiaomei
    Ke, Yao
    Zhao, Ling
    Chen, Lin
    Wu, Rui
    Wu, Zhenbiao
    Zuo, Xiaoxia
    Xie, Yanli
    Chen, Jinwei
    Wei, Wei
    Liu, Yi
    Li, Zhijun
    Dai, Lie
    Sun, Lingyun
    Liu, Xiangyuan
    Li, Zhanguo
    [J]. LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2021, 10
12345